摘要
1693年金鸡纳因其突出的治疟效力传入中国,初现于宫廷但中国官方文献记载寥寥,18世纪中叶后私人著作与报刊中记录颇多,金鸡纳及其相关知识有了较大的社会接受面。金鸡纳在中国的引种时间始于1874年,最早成功种植的记录在1876年,比此前学界所认为的年份提早许多。19世纪上半叶,由于化学技术进步与国际市场影响,生药金鸡纳逐渐被化合药奎宁取代。奎宁治疟在中国最早由海关外籍医生引入使用,并很快被中国西医接受,且具备了在临床上注重服药时间并使用他药配合的经验;20世纪以后,奎宁被纳入中医药体系,很快实现早期的中西医结合治疟。以金鸡纳为例,探索近代中国对外来药物的接受过程,有助于研究当下全球传染病流行中新理念、新药物的推广。
In 1693,Jin Ji Na(Cinchona)was introduced into China because of its prominent efficacy in treating malaria.It first appeared in the royal court with few official records,and had been documented increasingly both in personal works and journals since mid-18th century,which produced a wider social receptance of Cinchona and related knowledge.The planting attempt of Cinchona in China began in 1874,and the earliest successful planting was recorded in 1876,much earlier than previous academic judgement.In thefirst half of the 19th century,the crude drug of Cinchona was gradually replaced by the synthetic quinine due to the progress of chemical technology and the influence of international market.Quinine was introduced by foreign doctors in the customs for the treatment of malaria in China,and was soon accepted by Chinese western doctors with accumulating experiences of paying attention to the time of medication and using adjuvant drugs in clinical practice.After the 20th century,quinine was incorporated into the traditional Chinese medicine system,and served as an early example of integrated treatment of Chinese and Western medicines for malaria.Based on the research of Cinchona,exploring the process of acceptance of foreign drugs in modern China is beneficial to researches on the promotion of new concepts and medicines in the current global epidemic of infectious diseases.
作者
薛莉
XUE Li(Center for Historical Geography,Fudan University,Shanghai 200433,China)
出处
《中医药文化》
2023年第4期316-324,共9页
Chinese Medical Culture
作者简介
薛莉(ORCID:0000-0002-7876-3628),博士生,E-mail:xuelishellyhsueh@163.com。
